.

Name : Mr. AMIT KUMAR

Lab No. : 431486969 Age : 21 Years
Ref By : Dr. IGMC SHIMLA Gender : Male
Collected : 22/1/2023 1:18:00PM Reported : 24/1/2023 9:27:36AM
A/c Status : P Report Status : Final
Collected at : LPL-SHIMLA Processed at : LPL-NATIONAL REFERENCE LAB
1st Floor sarab complex, NH-20 Shimla To National Reference laboratory, Block E,
Rampur highway, Sanjauli Main Market, Sector 18, Rohini, New Delhi -110085
Shimla-171006

Test Report

Test Name Results Units Bio. Ref. Interval

HEPATITIS B VIRAL (HBV DNA) QUANTITATIVE, 2702027 IU/mL

REAL TIME PCR
(Real Time PCR – Taqman technology)

Interpretation
--------------------------------------------------------------------------------------------
| RESULT in IU/mL | REMARKS |
|---------------------|----------------------------------------------------------------------|
| Target not detected | Sample provided does not contain HBV DNA |
|---------------------|----------------------------------------------------------------------|
| < 20 | HBV DNA detected, but below the lower limit of linear range of the |
| | assay.These results should be interpreted with caution |
|---------------------|----------------------------------------------------------------------|
| >=20 to< 1.7x10 ⁸ | HBV DNA detected within the linear range of the assay |
|---------------------|----------------------------------------------------------------------|
| >= 1.7 x 10 ⁸ | HBV DNA detected above the linear range of the assay |
--------------------------------------------------------------------------------------------

Note
1. Linear reporting range of the assay is 20 - 1.7 x 10 ⁸ IU/mL
2. Conversion factor: 1 IU/mL = 5.82 copies / mL
3. Test conducted on Serum / Plasma
4. This test is not intended for use as a screening test for the presence of HBV in blood or blood products
or as a diagnostic test to confirm the presence of HBV infection
5. HBV genotyping and Drug resistance is recommended in positive cases if value is >2000 IU/mL

Comments
Hepatitis B Virus (HBV) is a member of Hepadna virus family transmitted primarily by body fluids especially
serum; sexual transmission and transmission from mother to baby. Majority of the infected individuals recover
completely; about 1-2% have persistent viral replication leading to chronic hepatitis. Frequency of chronic HBV
infection is 5-10% in immunocompromised patients and 80% in neonates.

Uses
· Monitoring response to therapy in chronic HBV infection
· Predict response to favourable treatment outcome
· A valuable tool when used in conjunction with other serological markers in the management of HBV
infection

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*431486969*
Page 1 of 3
.

Name : Mr. AMIT KUMAR

Lab No. : 431486969 Age : 21 Years
Ref By : Dr. IGMC SHIMLA Gender : Male
Collected : 22/1/2023 1:18:00PM Reported : 24/1/2023 9:27:36AM
A/c Status : P Report Status : Final
Collected at : LPL-SHIMLA Processed at : LPL-NATIONAL REFERENCE LAB
1st Floor sarab complex, NH-20 Shimla To National Reference laboratory, Block E,
Rampur highway, Sanjauli Main Market, Sector 18, Rohini, New Delhi -110085
Shimla-171006

Test Report

Test Name Results Units Bio. Ref. Interval

HEPATITIS B SURFACE ANTIBODY (Anti-HBs), 18.01 mIU/mL <10.00

SERUM
(CMIA)
*Reference range is defined as per CLSI guidelines and WHO International Standard for Anti-HBs*

Interpretation
-----------------------------------------------------------------------------------------------
| RESULT IN mIU/mL | REMARKS | INTERPRETATION |
|--------------------|--------------|-----------------------------------------------------------|
| <10 | Non-Reactive | Indicates absence of antibodies to Hepatitis B Surface |
| | | Antigen. |
|--------------------|--------------|-----------------------------------------------------------|
| >=10 | Reactive | Indicates presence of antibodies to Hepatitis B Surface |
| | | Antigen. |
-----------------------------------------------------------------------------------------------

Note
1. Reactive test result indicates presence of antibodies to Hepatitis B Surface Antigen. Detection of
Anti-HBs antibodies is observed in recent Hepatitis B viral infection, resolved Hepatitis B viral infection
and after successful HBV vaccination.
2. This assay does not differentiate between a vaccine induced immune response and an immune
response induced by infection with HBV.
3. Non-Reactive test result indicates absence of antibodies to Hepatitis B Surface Antigen.
4. False positive results may be observed in patients receiving mouse monoclonal antibodies, on
heparin therapy, on biotin supplements for diagnosis or therapy, presence of heterophilic antibodies in
serum.
5. False negative reaction may be due to processing of sample collected early in the course of disease,
presence of mutant forms of HBsAg and immunocompromised / immunosuppressed conditions.
6. Test conducted on serum.

Uses
· To determine immune status to HBV or disease progression in individuals infected with HBV
· To determine if vaccination is needed
· To determine if protective immunity has been achieved following a vaccination regimen.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*431486969*
Page 2 of 3
.

Name : Mr. AMIT KUMAR

Lab No. : 431486969 Age : 21 Years
Ref By : Dr. IGMC SHIMLA Gender : Male
Collected : 22/1/2023 1:18:00PM Reported : 24/1/2023 9:27:36AM
A/c Status : P Report Status : Final
Collected at : LPL-SHIMLA Processed at : LPL-NATIONAL REFERENCE LAB
1st Floor sarab complex, NH-20 Shimla To National Reference laboratory, Block E,
Rampur highway, Sanjauli Main Market, Sector 18, Rohini, New Delhi -110085
Shimla-171006

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Shalabh Malik Dr Vamshi Krishna Thamtam

MD, Microbiology
Technical Director - Microbiology,
Infectious Disease Molecular &
Serology, Clinical Pathology
NRL - Dr Lal PathLabs Ltd
MD,Pathology, PDF (Genetics)
Head - Genomics
NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIBPANLCAMMLPCBILLJCECCIKCIKPINKEDFJFAPPAHEEEHA
BNFFFNBPAPBKJKEGFGEGAOIPAOAHFHAKAKNOBCJCNLEKMGJHMPBNFFFNB
CIEGCDFLPPPEPFBOPFIAAJHFJCFEHEDLPKPHENFLMLKIOEFLBLGDEHANP
DJMIMCFNBHFIEDINCLMELFMFANPLALBFJIFEOAPAKCLJPDNLIJPBKEMEK
KDGCLHFJOFFFDIAGLCDCKPJKJENDODCHKKMHGEMIPLKGKPNGKFFFOOKID
DFCBBEFMNICGDIEKIHEHMIPBADHFOFAINCFCBKDLALIKOMNALNEIOOMCD
HHIMIJFJELOBDFGIEKMHEHEHIHAFJBAKPLMPBLMAIJCHKJNDAJNNMDILD
NJJJAMFMBINBBEPJGANHDCMILKBMFMBBOFCCAMNNIIKNOPNKBNFMAHILL
NKNODHFIKAOGFAAIENNIHIEKHGBFEKFBJFFLALPFOOBIOCNKDJPHNEKLJ
NNMAEMFCEDFJJDCNPIHFGPNJBDFKPNJHKEPBELFLNKCKIGEOCGOKHMAML
AKIKOLFLGKCBMMCMPFBDOJEEINMGHFMBJMFEBFOFPNDMKPFKEPCIGKIMG
AOICGJFCPLDNBFEMHHGFMNBEIEOPPFOFAOPPBLNOOLJBIKNJPKONHDICL
MNNNNNEHCGAINKOJOCFLHIEHJBAHFHADNKPFCMNLMKJCLFNJAHFHAHIKL
APBBBPAPBKOAEJBPBPBKCFKFAEHCHHCAONFFPKPGOLMHNLNNEDFFDBKHH
HHHHHHHPHHHPHPPHPHHPPPHPHHPPPPPPPPPHHPHPPHHHPHPHHHHPHHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for
derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe Courts/Forum
at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico legal
purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor.ŸThe report does
not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*431486969*
Page 3 of 3